Mechanism of resistance to several antimicrobial agents in Salmonella clinical isolates causing traveler's diarrhea

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 10, 2004, Pages 3934-3939

  Cabrera, Roberto ^a,b,c   Ruiz, Joaquím ^a   Marco, Francesc ^a   Oliveira, Inés ^a   Arroyo, Margarita ^b   Aladueña, Ana ^b   Usera, Miguel A ^b   Jiménez De Anta, M Teresa ^a   Gascón, Joaquím ^a   Vila, Jordi ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINO ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFTAZIDIME; CHLORAMPHENICOL; CHLORAMPHENICOL ACETYLTRANSFERASE; CIPROFLOXACIN; COTRIMOXAZOLE; DIHYDROFOLATE REDUCTASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG MECHANISM; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; TRAVELLER DIARRHEA;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGE TYPING; DIARRHEA; DNA GYRASE; DNA PRIMERS; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA; SALMONELLA INFECTIONS; SEROTYPING; TRAVEL;

EID: 4644233170     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.10.3934-3939.2004     Document Type: Article

References (43)

1. Baucheron, S., H. Imberechts, E. Chlaslus-Dancla, and A. Cloeckaert. 2002. The AcrB multidrugs transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT 204. Microb. Drug Resist. 8:285-289.
2. Bauer, A., W. M. M. Kirby, J. C. Sherris, and M. Truck. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.
3. Brisabois, A., I. Cazin, J. Breuil, and E. Collatz. 1997. Vigilancia de la resistencia a antibióticos de Salmonella. Eurosurv. Month 2:19-20.
4. Brown, J. C., C. J. Thomson, and S. G. Amyes. 1996. Mutation of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs. Antimicrob. Agents Chemother. 37:351-356.
5. Bush, K. 2001. New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089.
6. Gallardo, F., J. Ruiz, F. Marco, K. J. Towner, and J. Vila. 1999. Increase in incidence to resistance to ampicillin, chloramphenicol, and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J. Med. Microbiol. 48:367-374.
7. Gascón, J., J. Vila, M. E. Walls, J. Ruiz, J. Vidal, M. Corachan, G. Prats, and M. T. Jiménez de Anta. 1993. Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur. J. Epidemiol. 9:217-223.
8. Giraud, E., A. Cloeckaert, S. Baucheron, C. Mouline, and E. Chaslus-Dancla. 2003. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J. Med. Microbiol. 52:697-703.
9. Graham, S. M., A. L. Walsh, E. M. Molyneux, A. J. Phiri, and M. E. Molineux. 2000. Clinical presentation of non-typhoidal Salmonella bacteriaemia in Malawian children. Trans R. Soc. Trop. Med. Hyg. 94:310-314.
10. Guardabassi, L., L. Dijkshoorn, J. M. Collard, and J. E. Olsen Dalsgaard. 2000. Distribution and in vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. J. Med. Microbiol. 49:929-936.
11. Guerra, B., B. Malorny, A. Schroeter, and R. Helmuth. 2003. Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany. Antimicrob. Agents Chemother. 47:2059.
12. Hakanen, A., P. Kotilainen, P. Huovinen, H. Helenius, and A. Siitonens. 2001. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg. Infect. Dis. 7:996-1003.
13. Hansen, H., and P. Heisig. 2003. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro. Microb. Drug Resist. 9:25-32.
14. Hartman, A. B., I. I. Essiet, D. W. Isenbarger, and L. E. Linder. 2003. Epidemiology of tetracycline resistance determinants in Shigella spp. an enteroinvasive Escherichia coli: characterization and dissemination of Tet (A)-1. J. Clin. Microbiol. 41:1023-1032.
15. Hoge, C. W., J. M. Gambel, A. Srijan, C. Pitarangsi, and P. Echeverría. 1998. Trends in antimicrobial resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin. Infect. Dis. 26:341-345.
16. Isenbarger, D. W., C. W. Hoge, A. Srijan, C. Pitarangsi, N. Vithayasai, L. Bodhidatta, K. W. Hickey, and P. Dac Cam. 2002. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg. Infect. Dis. 8:175-180.
17. Khan, W. A., C. Seas, U. Dhar, M. A. Salam, and M. L. Bennish. 1997. Treatment of shigellosis. V. Comparison of azithromycin and ciprofloxacin. Ann. Intern. Med. 126:697-703.
18. Lawson, A. J., M. U. Dassama, L. R. Ward, and E. J. Threlfall. 2000. Multiply resistant (MR) Salmonella enterica serotype Typhimurium DT 12 and DT 120: a case of MR DT 104 in disguise? Emerg. Infect. Dis. 8:434-436.
19. Moreira Lima, A. A. 2001. Tropical diarrhoea: new developments in traveller's diarrhoea. Curr. Opin. Infect. Dis. 14:547-552.
20. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1995. Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
21. Mwansa, J., K. Mutela, I. Zulu, B. Amadi, and P. Kelly. 2002. Antimicrobial sensitivity in enterobacteria from AIDS patients, Zambia. Emerg. Infect. Dis. 8:92-93.
22. Nakaya, H., A. Yasuhara, K. Yoshimura, Y. Oshihoi, H. Izumiva, and H. Watanabe. 2003. Life-threatening infantile diarrhea from fluoroquinolone- resistant Salmonella enterica Typhimurium with mutation in both gyrA and parC Emerg. Infect. Dis. 9:255-257.
23. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing, 9th ed. Approved standard M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Navia, M. M., L. Capitano, J. Ruiz, M. Vargas, H. Urassa, D. Schellemberg, J. Gascón, and J. Vila. 1999. Typing and characterization of mechanisms of resistance Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J. Clin. Microbiol. 37:3113-3117.
25. Navia, M. M., J. Ruiz, J. Sánchez Céspedes, and J. Vila. 2003. Detection of dihydrofolate reductase genes by PCR and RFLP. Diagn. Microbiol. Infect. Dis. 46:295-298.
26. Ng, L.-K., M. R. Mulvey, I. Martin, G. A. Peters, and W. Johnson. 1999. Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104. Antimicrob. Agents Chemother. 43:3018-3021.
27. Orman, Be., S. A. Piñeiro, S. Arduino, M. Galas, R. Melano, M. I. Caffer, D. O. Sordelli, and D. Centrón. 2002. Evolution of multiresistance in no typhoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother. 46:3963-3970.
28. Roberts, M. C. 1996. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microb. Rev. 19:1-24.
29. Roy, C., A. Foz, C. Segura, M. Tirado, C. Fuster, and R. Reig. 1983. Plasmid-determined β-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. J. Antimicrob. Chemother. 12:507-510.
30. Ruiz, J., D. Castro, P. Goñi, J. A. Santamaria, J. J. Borrego, and J. Vila. 1997. Analysis of the mechanism of quinolone-resistance in nalidixic acid-resistance clinical isolates of Salmonella serotype Typhimurium. J. Med. Microbiol. 46:623-628.
31. Shapiro, R. L., L. Kumar, P. Phillips-Howard, J. G. Wells, P. Adcock, J. Brooks, M. L. Ackers, J. B. Oshieng, E. Mintz, S. Wahlquist, P. Waiyaki, and L. Slutsker. 2001. Antimicrobial resistance bacterial diarrhea in rural Western Kenya. J. Infect. Dis. 183:1701-1704.
32. Soto, S. M., J. Ruiz, M. C. Mendoza, and J. Vila. 2003. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance. Int. J. Antimicrob. Agents. 22:537-540.
33. Stapleton, P., P. Wu, A. King, K. Shanon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39: 2478-2483.
34. Stock, I., and B. Wiedemann. 2000. Natural antibiotic susceptibility of Salmonella enteric strains. Int. J. Antimicrob. Agents 16:211-217.
35. Szych, J., A. Cieslik, J. Pacioreck, and S. Kaluzewski. 2001. Antibiotic resistance in Salmonella enterica subsp. enterica strains isolated in Poland from 1998 to 1999. Int. J. Antimicrob. Agents. 18:37-42.
36. Venolakis, E. N., A. Markogiannakis, L. Kondili, E. Varjioti, Z. Mahera, E. Dedouli, A. Karaitianou, N. Vakalis, and K. Bethimouti. 2001. Evolución de la resistencia a antibióticos de Salmonellas no tifoideas en Grecia durante el período comprendido entre 1990 y 1997. Eurosurv. Month 6:117-120.
37. Vila, J., J. Gascón, S. Abdalla, J. Gómez, A. Moreno, M. Corachán, and M. T. Jimenez de Anta. 1995. Antimicrobial resistance of nontyphoidal Salmonella isolates in traveller's diarrhea. J. Travel Med. 2:45-47.
38. Vila, J., J. Gascón, S. Abdalla, J. Gómez, A. Moreno, M. Corachán, and M. T. Jimenez de Anta. 1994. Antimicrobial resistance of Shigella isolates causing traveler's diarrhoea. Antimicrob. Agents Chemother. 38:2668-2670.
39. Vila, J., M. Vargas, J. Ruiz, M. Corachán, M. T. Jiménez de Anta, and J. Gascón. 2000. Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with travelers to other geographical areas. Antimicrob. Agents Chemother. 44:1731-1733.
40. Vila, J., M. Vargas, J. Ruiz, M. Espasa, M. Pujol, M. Corachán, M. T. Jiménez de Anta, and J. Gascón. 2001. Susceptibility patterns of enteroaggregative Escherichia coli associated to traveller's diarrhoea: emergence of quinolone resistance. J. Med. Microbiol. 50:996-1000.
41. Wain, J., N. T. T. Hoa, N. T. Chinh, H. Vinh, M. J. Everett, T. S. Diep, N. P. J. Day, T. Solomon, N. J. White, L. J. V. Piddock, and C. M. Parry. 1997. Quinolone-resistant Salmonella typhi in Vietnam: molecular basis of resistance and clinical response to treatment. Clin. Infect. Dis. 25:1404-1410.
42. Walker, R. A., E. Lindsay, M. J. Wooward, L. R. Ward, and J. Threlfall. 2001. Variation in clonality and antibiotic-resistance genes among multiresistant Salmonella enterica serotype Typhimurium phage-type U302 (MR U302) from humans, animals, and foods. Microb. Drug Resist. 7:13-21.
43. Zahurul Haque Asna, S. M., J. Ashraful Haq, and M. D. Mushfequr Rahman. 2003. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. Jpn. J. Infect. Dis. 56:32-33.